| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |